[Physiopathological basis for a tailored management of essential hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000584:Amiloride / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008124:Locomotion; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000032:analysis; D011719:Pyrazines / Q000627:therapeutic use*; D012083:Renin / Q000097:blood; D012964:Sodium / Q000032:analysis
D000319:Adrenergic beta-Antagonists; D004338:Drug Combinations; D011719:Pyrazines; D006852:Hydrochlorothiazide; D000584:Amiloride; D012964:Sodium; D012083:Renin; D011188:Potassium
Basi fisiopatologiche per una terapia mirata dell'ipertensione essenziale.